COMMUNIQUÉS West-GlobeNewswire

Cutera to Present at the Sidoti Spring 2018 Investor Conference
20/03/2018
BRISBANE, Calif., March 20, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, [...]
SIGA Technologies Announces Relisting on Nasdaq
20/03/2018
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA ), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs [...]
KemPharm Announces Positive Topline Results from KP415 Pharmacokinetic Study in Children and Adolescents With ADHD
20/03/2018
Results Suggest that Data from Single Classroom-style Efficacy Study May Be Applicable Across Pediatric, Adolescent and Adult ADHD Patient Populations CORALVILLE, Iowa, March 20, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc [...]
New Analyses Confirm Patients with Medtronic CRT Devices Experience Less Atrial Fibrillation, Are More Active
20/03/2018
Positive Data on Exclusive AdaptivCRT(TM) Feature Unveiled at EHRA Scientific Sessions 2018 DUBLIN and BARCELONA, Spain - March 20 , 2018 - Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) [...]
Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in Journal of Experimental Medicine
20/03/2018
WAYNE, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Merus and the Vall d’Hebron Institute of Oncology Announce Research Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Applications in the Treatment of Cancer
20/03/2018
UTRECHT, The Netherlands, March 20, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics ® ), and the Vall d’ [...]
Trillium Therapeutics’ TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-Cell Lymphoma
20/03/2018
TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq: TRIL ) (TSX: TRIL ), an immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that the U.S. [...]
Cotinga Pharmaceuticals Provides Update on COTI-2 Clinical Programs
20/03/2018
LONDON, Ontario and BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of [...]
Kane Biotech to Showcase bluestem™ Pet Oral Care Products and New Skin Care Shampoo at the 14th Annual Global Pet Expo
20/03/2018
WINNIPEG, Manitoba, March 20, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that for the third consecutive year it will be attending [...]
Hydropothecary selects Shopify to power ecommerce services for medical and recreational cannabis markets
20/03/2018
GATINEAU, Quebec, March 20, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSX-V: THCX ) (“Hydropothecary”) has reached an agreement with Shopify, one of the world’s most respected online commerce companies, [...]
Hydropothecary choisit Shopify pour ses services de commerce électronique destinés aux marchés du cannabis à fins médicales et récréatives
20/03/2018
GATINEAU, Québec, 20 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (« Hydropothecary ») a conclu une entente avec Shopify, l’une des entreprises de commerce en ligne les plus respectées [...]
Carolina Complete Health Network Announces Public Offering of Class P Common Stock
20/03/2018
RALEIGH, N.C., March 20, 2018 (GLOBE NEWSWIRE) -- Carolina Complete Health Network, Inc. (CCHN), a company formed to build and support a patient-focused, physician-led Medicaid health network, today announced that it [...]
PotNetwork Holding, Inc. Senior Advisor Bruce BarrenBarren to appear on National Radio and Webcast Today, Tuesday March 20th, 2018
20/03/2018
FT LAUDERDALE, Fla., March 20, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding, Inc. (OTC Pink:POTN) Today, Tuesday the 20th of March in 2018, PotNetwork Holding Inc. Senior Advisor Bruce Barren is [...]
AC Immune reports full-year 2017 financial results - successful first year as a public company
20/03/2018
Lausanne, Switzerland, March 20, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced financial results [...]
Helsinn Group Announces First Patient Enrolled in Phase 3b Study of NEPA IV vs NEPA Oral for the prevention of chemotherapy induced nausea and vomiting (CINV) in Women with Breast Cancer
20/03/2018
Lugano, Switzerland, March 20, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announced that the first patient has been enrolled in a Phase 3b study to assess the [...]
Herantis Pharma's Annual Report 2017 published
20/03/2018
Herantis Pharma's Annual Report 2017 published Herantis Pharma Plc Company release 20 March 2018 at 9:00 am Herantis Pharma Plc's Annual Report for the year 2017 has been published today. The Annual Report contains [...]
Immunicum AB: Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data
20/03/2018
Press Release 20 March 2018 Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing [...]
Shire plc : New Data Presented at the Endocrine Society's 2018 Annual Meeting Advances Understanding of the Rare Disease Chronic Hypoparathyroidism
20/03/2018
New Data Presented at the Endocrine Society's 2018 Annual Meeting Advances Understanding of the Rare Disease Chronic Hypoparathyroidism - Clinical and real-world data on chronic hypoparathyroidism provides new insights [...]
Motif Bio Update on NDA Submission for Iclaprim
20/03/2018
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today provided an update on the status and [...]

Pages